Pancreatic Cancer Research

ResearcherJilin UniversityNo recent work listed

Guangyi Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-1710-2196; OpenAlex author ID A5100709315. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 3

  1. Comprehensive Analysis on Prognosis and Immune Infiltration of Lysyl Oxidase Family Members in Pancreatic Adenocarcinoma With Experimental Verification. Last author DOI 10.3389/fmolb.2022.778857↗
  2. mTOR inhibition induces EGFR feedback activation in association with its resistance to human pancreatic cancer. Co-author DOI 10.3390/ijms16023267↗
  3. miR-99b-targeted mTOR induction contributes to irradiation resistance in pancreatic cancer. Co-author DOI 10.1186/1476-4598-12-81↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chao Jiang · 1 shared paper, 2022 · strength 0.19
  2. Guoyue Lv · 1 shared paper, 2022 · strength 0.19
  3. Yan Liu · 2 shared papers, 2013–2015 · strength 0.10
  4. Wei Feng · 2 shared papers, 2013–2015 · strength 0.10
  5. Zifan Lu · 1 shared paper, 2013 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.